composições e métodos para degradação de proteína seletiva

trata-se de composições incluindo um polipeptídeo de fusão e métodos para produzir um polipeptídeo de fusão que inclui um polipeptídeo de ligação a cof1/crbn, polipeptídeo de ligação a cof2/crbn ou polipeptídeo de ligação a cof3/crbn e um polipeptídeo heterólogo de interesse. The invention provides...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CARLA PATRICIA PINTO GUIMARAES, CARLETON PROCTOR GOOLD, MARC HORST PETER HILD, NATHAN THOMAS ROSS, JONATHAN M. SOLOMON, SETH CARBONNEAU, GREGORY MOTZ, ROHAN ERIC JOHN BECKWITH, ANDREI GOLOSOV, JAMES E. BRADNER
Format: Patent
Sprache:por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CARLA PATRICIA PINTO GUIMARAES
CARLETON PROCTOR GOOLD
MARC HORST PETER HILD
NATHAN THOMAS ROSS
JONATHAN M. SOLOMON
SETH CARBONNEAU
GREGORY MOTZ
ROHAN ERIC JOHN BECKWITH
ANDREI GOLOSOV
JAMES E. BRADNER
description trata-se de composições incluindo um polipeptídeo de fusão e métodos para produzir um polipeptídeo de fusão que inclui um polipeptídeo de ligação a cof1/crbn, polipeptídeo de ligação a cof2/crbn ou polipeptídeo de ligação a cof3/crbn e um polipeptídeo heterólogo de interesse. The invention provides compositions including a fusion polypeptide and methods for making a fusion polypeptide that includes a COF1/CRBN-binding polypeptide, COF2/CRBN-binding polypeptide, or COF3/CRBN-binding polypeptide and a heterologous polypeptide of interest.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR112020007576A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR112020007576A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR112020007576A23</originalsourceid><addsrcrecordid>eNrjZHBIzs8tyC_OPLz88NbUYoVUhdzDK0vyU_KLFQoSixIVUlLTixJTEoGyi_OBHIWCovyS1MNr8xIVilNzUksyyxJ5GFjTEnOKU3mhNDeDqptriLOHbmpBfnxqcUFicmpeakm8U5ChoZGBkYGBgbmpuZmjkTGx6gBuiTbs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>composições e métodos para degradação de proteína seletiva</title><source>esp@cenet</source><creator>CARLA PATRICIA PINTO GUIMARAES ; CARLETON PROCTOR GOOLD ; MARC HORST PETER HILD ; NATHAN THOMAS ROSS ; JONATHAN M. SOLOMON ; SETH CARBONNEAU ; GREGORY MOTZ ; ROHAN ERIC JOHN BECKWITH ; ANDREI GOLOSOV ; JAMES E. BRADNER</creator><creatorcontrib>CARLA PATRICIA PINTO GUIMARAES ; CARLETON PROCTOR GOOLD ; MARC HORST PETER HILD ; NATHAN THOMAS ROSS ; JONATHAN M. SOLOMON ; SETH CARBONNEAU ; GREGORY MOTZ ; ROHAN ERIC JOHN BECKWITH ; ANDREI GOLOSOV ; JAMES E. BRADNER</creatorcontrib><description>trata-se de composições incluindo um polipeptídeo de fusão e métodos para produzir um polipeptídeo de fusão que inclui um polipeptídeo de ligação a cof1/crbn, polipeptídeo de ligação a cof2/crbn ou polipeptídeo de ligação a cof3/crbn e um polipeptídeo heterólogo de interesse. The invention provides compositions including a fusion polypeptide and methods for making a fusion polypeptide that includes a COF1/CRBN-binding polypeptide, COF2/CRBN-binding polypeptide, or COF3/CRBN-binding polypeptide and a heterologous polypeptide of interest.</description><language>por</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200924&amp;DB=EPODOC&amp;CC=BR&amp;NR=112020007576A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200924&amp;DB=EPODOC&amp;CC=BR&amp;NR=112020007576A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CARLA PATRICIA PINTO GUIMARAES</creatorcontrib><creatorcontrib>CARLETON PROCTOR GOOLD</creatorcontrib><creatorcontrib>MARC HORST PETER HILD</creatorcontrib><creatorcontrib>NATHAN THOMAS ROSS</creatorcontrib><creatorcontrib>JONATHAN M. SOLOMON</creatorcontrib><creatorcontrib>SETH CARBONNEAU</creatorcontrib><creatorcontrib>GREGORY MOTZ</creatorcontrib><creatorcontrib>ROHAN ERIC JOHN BECKWITH</creatorcontrib><creatorcontrib>ANDREI GOLOSOV</creatorcontrib><creatorcontrib>JAMES E. BRADNER</creatorcontrib><title>composições e métodos para degradação de proteína seletiva</title><description>trata-se de composições incluindo um polipeptídeo de fusão e métodos para produzir um polipeptídeo de fusão que inclui um polipeptídeo de ligação a cof1/crbn, polipeptídeo de ligação a cof2/crbn ou polipeptídeo de ligação a cof3/crbn e um polipeptídeo heterólogo de interesse. The invention provides compositions including a fusion polypeptide and methods for making a fusion polypeptide that includes a COF1/CRBN-binding polypeptide, COF2/CRBN-binding polypeptide, or COF3/CRBN-binding polypeptide and a heterologous polypeptide of interest.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHBIzs8tyC_OPLz88NbUYoVUhdzDK0vyU_KLFQoSixIVUlLTixJTEoGyi_OBHIWCovyS1MNr8xIVilNzUksyyxJ5GFjTEnOKU3mhNDeDqptriLOHbmpBfnxqcUFicmpeakm8U5ChoZGBkYGBgbmpuZmjkTGx6gBuiTbs</recordid><startdate>20200924</startdate><enddate>20200924</enddate><creator>CARLA PATRICIA PINTO GUIMARAES</creator><creator>CARLETON PROCTOR GOOLD</creator><creator>MARC HORST PETER HILD</creator><creator>NATHAN THOMAS ROSS</creator><creator>JONATHAN M. SOLOMON</creator><creator>SETH CARBONNEAU</creator><creator>GREGORY MOTZ</creator><creator>ROHAN ERIC JOHN BECKWITH</creator><creator>ANDREI GOLOSOV</creator><creator>JAMES E. BRADNER</creator><scope>EVB</scope></search><sort><creationdate>20200924</creationdate><title>composições e métodos para degradação de proteína seletiva</title><author>CARLA PATRICIA PINTO GUIMARAES ; CARLETON PROCTOR GOOLD ; MARC HORST PETER HILD ; NATHAN THOMAS ROSS ; JONATHAN M. SOLOMON ; SETH CARBONNEAU ; GREGORY MOTZ ; ROHAN ERIC JOHN BECKWITH ; ANDREI GOLOSOV ; JAMES E. BRADNER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR112020007576A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CARLA PATRICIA PINTO GUIMARAES</creatorcontrib><creatorcontrib>CARLETON PROCTOR GOOLD</creatorcontrib><creatorcontrib>MARC HORST PETER HILD</creatorcontrib><creatorcontrib>NATHAN THOMAS ROSS</creatorcontrib><creatorcontrib>JONATHAN M. SOLOMON</creatorcontrib><creatorcontrib>SETH CARBONNEAU</creatorcontrib><creatorcontrib>GREGORY MOTZ</creatorcontrib><creatorcontrib>ROHAN ERIC JOHN BECKWITH</creatorcontrib><creatorcontrib>ANDREI GOLOSOV</creatorcontrib><creatorcontrib>JAMES E. BRADNER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CARLA PATRICIA PINTO GUIMARAES</au><au>CARLETON PROCTOR GOOLD</au><au>MARC HORST PETER HILD</au><au>NATHAN THOMAS ROSS</au><au>JONATHAN M. SOLOMON</au><au>SETH CARBONNEAU</au><au>GREGORY MOTZ</au><au>ROHAN ERIC JOHN BECKWITH</au><au>ANDREI GOLOSOV</au><au>JAMES E. BRADNER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>composições e métodos para degradação de proteína seletiva</title><date>2020-09-24</date><risdate>2020</risdate><abstract>trata-se de composições incluindo um polipeptídeo de fusão e métodos para produzir um polipeptídeo de fusão que inclui um polipeptídeo de ligação a cof1/crbn, polipeptídeo de ligação a cof2/crbn ou polipeptídeo de ligação a cof3/crbn e um polipeptídeo heterólogo de interesse. The invention provides compositions including a fusion polypeptide and methods for making a fusion polypeptide that includes a COF1/CRBN-binding polypeptide, COF2/CRBN-binding polypeptide, or COF3/CRBN-binding polypeptide and a heterologous polypeptide of interest.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language por
recordid cdi_epo_espacenet_BR112020007576A2
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title composições e métodos para degradação de proteína seletiva
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T07%3A39%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CARLA%20PATRICIA%20PINTO%20GUIMARAES&rft.date=2020-09-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR112020007576A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true